# RESEARCH PROTOCOL DOCUMENTATION INDEX
## Propolis-Coated Collagen Membrane for Guided Bone Regeneration

**Project Title**: Propolis-Coated Collagen Membranes as Multi-Functional Barriers for Enhanced Guided Bone Regeneration  
**Institution**: [Your Research Institution]  
**Date Created**: January 27, 2026  
**Document Version**: 1.0 (Final - Ready for Execution)  
**Status**: Protocol Development Complete âœ“

---

## QUICK NAVIGATION

### Core Documents (Read in This Order)

1. **[00-RESEARCH-PROPOSAL.md](00-RESEARCH-PROPOSAL.md)** - START HERE
   - Executive summary and research rationale
   - Feasibility assessment (8.5/10 viability score)
   - Research objectives and specific aims
   - Expected outcomes and clinical impact
   - **Read Time**: 20 minutes
   - **Key Decision**: Should this research be pursued? âœ“ YES

2. **[04-RESEARCH-TIMELINE.md](04-RESEARCH-TIMELINE.md)** - PLANNING & SCHEDULING
   - Complete 14-month project schedule
   - Phase-by-phase breakdown with weekly milestones
   - Personnel allocation and budget ($128,000 total)
   - Gantt chart and critical path analysis
   - GO/NO-GO decision points at each phase
   - **Read Time**: 30 minutes
   - **Key Decision**: Is timeline realistic? Can we commit resources? âœ“ YES

3. **[01-PHASE-1-EXTRACTION-PROTOCOL.md](01-PHASE-1-EXTRACTION-PROTOCOL.md)** - EXECUTION STARTS HERE
   - Propolis extraction & standardization (3 months)
   - Detailed QC protocols (TPC, TFC, DPPH, HPLC, microbial testing)
   - Quality control acceptance criteria
   - Batch-to-batch consistency validation
   - **Read Time**: 45 minutes
   - **Who Uses**: Material Scientist, Biochemist
   - **Start Date**: January 2026 (Month 1)

4. **[02-PHASE-2-COATING-PROTOCOL.md](02-PHASE-2-COATING-PROTOCOL.md)** - COATING DEVELOPMENT
   - Coating formulation design and development (2 months)
   - Layer-by-Layer (LbL) coating methodology
   - Comprehensive characterization (SEM, FTIR, mechanical testing, thermal analysis, release kinetics)
   - Degradation & antimicrobial studies
   - **Read Time**: 60 minutes
   - **Who Uses**: Material Scientist, Technician, Biochemist
   - **Start Date**: April 2026 (Month 4)

5. **[03-PHASE-3-INVITRO-PROTOCOL.md](03-PHASE-3-INVITRO-PROTOCOL.md)** - CELL CULTURE & MOLECULAR VALIDATION
   - In vitro osteogenic differentiation studies (4 months)
   - MC3T3-E1 cell culture & seeding protocol
   - Proliferation (MTT), differentiation (ALP), mineralization (alizarin red, calcium)
   - Gene expression analysis (qPCR for RUNX2, OCN, COL1A1, Osterix, OPN)
   - Statistical analysis and data compilation
   - **Read Time**: 60 minutes
   - **Who Uses**: Cell Biologist, Molecular Biologist, Technician
   - **Start Date**: June 2026 (Month 6)

6. **[05-EXPECTED-OUTCOMES.md](05-EXPECTED-OUTCOMES.md)** - IMPACT & PUBLICATION STRATEGY
   - Expected scientific outcomes (3-4 publications)
   - Publication timeline and journal targets
   - Clinical translation pathway (regulatory strategy)
   - Future research directions beyond initial project
   - **Read Time**: 40 minutes
   - **Key Outcomes**: 95-150 citations expected, potential for clinical translation

---

## DOCUMENT MAP BY PHASE

### Phase 1: Propolis Extraction & Standardization (Months 1-3)
ðŸ“„ **Main**: [01-PHASE-1-EXTRACTION-PROTOCOL.md](01-PHASE-1-EXTRACTION-PROTOCOL.md)  
ðŸ“‹ **Timeline**: Weeks 1-13 in [04-RESEARCH-TIMELINE.md](04-RESEARCH-TIMELINE.md) - See "Phase 1 Overview" section  
ðŸŽ¯ **Success Metrics**: [00-RESEARCH-PROPOSAL.md](00-RESEARCH-PROPOSAL.md) - "Phase 1 Success Metrics" section  

**Key Protocols**:
- Propolis extraction via ultrasonic-assisted extraction (UAE)
- Total Phenolic Content (TPC) assay (Folin-Ciocalteu method)
- Total Flavonoid Content (TFC) assay (Aluminum chloride method)
- Antioxidant activity (DPPH radical scavenging, IC50 determination)
- HPLC fingerprint analysis (6+ marker compounds)
- Microbial contamination testing
- Batch consistency validation (CV <15%)

**Deliverables**:
- âœ“ 3 QC-approved propolis extract batches (TPC >150 mg GAE/g)
- âœ“ Standardized extraction SOP with validated QC methods
- âœ“ Batch documentation spreadsheet
- âœ“ Stability assessment report (6-month baseline)

---

### Phase 2: Coating Development & Characterization (Months 4-5)
ðŸ“„ **Main**: [02-PHASE-2-COATING-PROTOCOL.md](02-PHASE-2-COATING-PROTOCOL.md)  
ðŸ“‹ **Timeline**: Weeks 14-24 in [04-RESEARCH-TIMELINE.md](04-RESEARCH-TIMELINE.md) - See "Phase 2 Overview" section  
ðŸŽ¯ **Success Metrics**: [00-RESEARCH-PROPOSAL.md](00-RESEARCH-PROPOSAL.md) - "Phase 2 Success Metrics" section  

**Key Protocols**:
- Collagen membrane substrate selection and baseline characterization
- Coating solution formulation (chitosan + propolis 0.5-2.5%)
- Layer-by-Layer (LbL) coating application (multi-layer assembly)
- Scanning Electron Microscopy (SEM) - morphology & thickness
- Fourier-Transform Infrared (FTIR) - functional group confirmation
- Mechanical property testing (tensile strength, elongation)
- Thermal analysis (DSC/TGA)
- Hydrophilicity assessment (contact angle, water uptake)
- 4-week release kinetics study (HPLC quantification)
- 12-week degradation study (mass loss, SEM evolution)
- Antimicrobial validation (disc diffusion assay)

**Deliverables**:
- âœ“ Optimized propolis-coated collagen membranes (50-100 samples)
- âœ“ Comprehensive characterization dataset (all physical/chemical properties)
- âœ“ Coating protocol SOP (validated, reproducible methodology)
- âœ“ Release kinetics and degradation profile graphs
- âœ“ Mechanical properties report (â‰¥80% strength retention confirmed)

---

### Phase 3: In Vitro Osteogenic Validation (Months 6-9)
ðŸ“„ **Main**: [03-PHASE-3-INVITRO-PROTOCOL.md](03-PHASE-3-INVITRO-PROTOCOL.md)  
ðŸ“‹ **Timeline**: Weeks 25-40 in [04-RESEARCH-TIMELINE.md](04-RESEARCH-TIMELINE.md) - See "Phase 3 Overview" section  
ðŸŽ¯ **Success Metrics**: [00-RESEARCH-PROPOSAL.md](00-RESEARCH-PROPOSAL.md) - "Phase 3 Success Metrics" section  

**Key Protocols**:
- MC3T3-E1 pre-osteoblast cell line culture maintenance
- Cell seeding on coated membranes (20,000 cells/well)
- 21-day osteogenic differentiation culture
- MTT viability assay (Days 1, 7, 14, 21)
- Alkaline Phosphatase (ALP) activity assay (Days 7, 14)
- Alizarin Red mineralization staining (Day 21)
- Calcium content quantification (Day 21)
- RNA extraction and qPCR gene expression analysis
  - Target genes: RUNX2, OCN, ALP, COL1A1, Osterix, OPN
  - Housekeeping genes: GAPDH, ACTB, 18S rRNA
  - Timepoints: Days 7, 14, 21
- Statistical analysis (ANOVA, Î”Î”Cq calculations)

**Deliverables**:
- âœ“ Comprehensive in vitro osteogenic data
- âœ“ MTT proliferation curves (Days 0-21)
- âœ“ ALP activity results (â‰¥1.3Ã— enhancement vs. uncoated)
- âœ“ Mineralization quantification (â‰¥1.5Ã— enhancement vs. uncoated)
- âœ“ Complete qPCR dataset (6 genes Ã— 3 timepoints Ã— 5 replicates)
- âœ“ Gene expression heatmaps and fold-change graphs
- âœ“ Statistical significance confirmed (p<0.05 for major markers)

---

### Phase 4: In Vivo GBR Efficacy Study (Months 10-14)
ðŸ“„ **Related**: [00-RESEARCH-PROPOSAL.md](00-RESEARCH-PROPOSAL.md) - "Expected Outcomes" section  
ðŸ“„ **Related**: [05-EXPECTED-OUTCOMES.md](05-EXPECTED-OUTCOMES.md) - "Outcome 4" section  
ðŸ“‹ **Timeline**: Weeks 41-61 in [04-RESEARCH-TIMELINE.md](04-RESEARCH-TIMELINE.md) - See "Phase 4 Overview" section  
âš ï¸ **Note**: Phase 4 detailed protocol (phase-4-invivo-protocol.md) to be developed in Month 9

**Key Protocols** (Summary):
- Wistar rat model, 5 mm critical-size calvaria defects
- 4 treatment groups: Empty defect, uncoated membrane, coated 1.0%, coated 1.5%
- Assessment timepoints: 4, 8, 12 weeks post-implantation
- Micro-CT volumetric analysis (BV/TV %, bone mineral density)
- Histomorphometric analysis (H&E staining, bone area %, trabecular thickness)
- Immunohistochemistry (RUNX2, OCN, VEGF expression)
- Statistical analysis

**Deliverables** (Expected):
- âœ“ Micro-CT volumetric data (all 3 timepoints)
- âœ“ Histomorphometric measurements
- âœ“ IHC imaging and quantification
- âœ“ In vivo efficacy confirmation (bone regeneration enhanced with coated membrane)
- âœ“ Safety profile validation (no adverse effects)

---

## QUICK REFERENCE TABLES

### Phase Success Criteria At a Glance

| Phase | Primary Success Criteria | Target | Status |
|-------|-------------------------|--------|--------|
| **Phase 1** | TPC â‰¥150 mg GAE/g, DPPH IC50 â‰¤0.2 mg/mL, CV <15% | 3 approved batches | Planning |
| **Phase 2** | Coating 1-5 Î¼m, Strength â‰¥80%, Release 60-80% | Optimized membrane | Planning |
| **Phase 3** | RUNX2/OCN â‰¥2Ã—, ALP â‰¥1.3Ã—, Calcium â‰¥1.5Ã— | Enhanced osteogenesis | Planning |
| **Phase 4** | Bone volume % â†‘ significantly, No adverse effects | GBR efficacy proven | Planning |

### Key Equipment Required

| Equipment | Used in Phase | Estimated Cost |
|-----------|--------------|---|
| Ultrasonic bath (40-50 kHz) | 1 | $2,000-3,000 |
| Rotary evaporator | 1,2 | $3,000-5,000 |
| Spectrophotometer (UV-Vis) | 1,2,3 | $2,000-4,000 |
| HPLC system | 1,2 | $25,000+ (or outsource $500/sample) |
| SEM (Scanning Electron Microscope) | 2 | $100,000+ (facility access) |
| FTIR spectrometer | 2 | $30,000-50,000 (facility access) |
| Mechanical tester (Instron) | 2 | $50,000+ (facility access) |
| DSC/TGA | 2 | $40,000-60,000 (facility access) |
| Tissue culture incubator (37Â°C, 5% COâ‚‚) | 3 | $3,000-5,000 |
| Biosafety Cabinet | 3 | $5,000-8,000 |
| qPCR system | 3 | $15,000-25,000 |
| Micro-CT scanner | 4 | $200,000+ (facility access) |

**Cost Strategy**: Acquire critical equipment ($10,000-15,000 budget), access facility equipment via university/core facilities/outsourcing for remainder

---

## TYPICAL RESEARCH TIMELINE BY MONTH

```
Month  Phase  Key Activities                          Personnel Time
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
  1    1      Supplier selection, extraction starts    Material Sci: 100%
  2    1      QC method development                   Biochemist: 80%
  3    1      Final batches, Phase 1 complete âœ“       Team: coordination
  4    2      Coating optimization starts             Material Sci: 100%
  5    2      Characterization, Phase 2 complete âœ“    Tech: 100%
  6    3      Cell culture setup & seeding            Cell Bio: 100%
  7    3      Day 7 sampling (qPCR start)             Mol Bio: 80%
  8    3      Day 14 sampling (ALP peak)              Tech: 100%
  9    3      Day 21 sampling, Phase 3 complete âœ“     Scientist: analysis
 10    4      IACUC approval, surgery planning        Surgeon: 50%
 11    4      Surgical implantation                   Surgeon: 50%
 12    4      4-week assessment (micro-CT)            Imaging: 30%
 13    4      8-week assessment, tissue harvest       Path: 50%
 14    4      12-week final assessment, Phase 4 âœ“     Analysis: 100%
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

---

## CRITICAL SUCCESS FACTORS

### Must Have (Non-Negotiable)
1. âœ“ **Phase 1 QC Standards Met**: TPC >150 mg GAE/g, DPPH <0.2 mg/mL
2. âœ“ **Phase 2 Coating Integrity**: â‰¥80% tensile strength retention
3. âœ“ **Phase 3 Osteogenic Enhancement**: RUNX2, OCN â‰¥2-fold vs. uncoated
4. âœ“ **Phase 4 In Vivo Efficacy**: Bone volume increased significantly at 12 weeks

### Should Have (Important for Impact)
- âœ“ Publication in high-impact journals (Biomaterials, Bone, Journal of Dental Research)
- âœ“ Statistical significance p<0.05 across major markers
- âœ“ Complete gene expression profile (6 genes Ã— 3 timepoints)
- âœ“ Mechanism understanding (propolis osteogenic pathway identified)

### Nice to Have (Enhances Value)
- âœ“ Patent application filed (propolis-collagen-bone regeneration)
- âœ“ Commercial partner interest/licensing discussion
- âœ“ Additional animal models (rabbit, mandible)
- âœ“ Clinical trial planning initiated

---

## TROUBLESHOOTING & RESOURCES

### Common Issues & Solutions

**Phase 1 Issues:**
- **Propolis extract variability**: Use certified supplier, maintain batch traceability
- **Low TPC values**: Adjust extraction parameters (temperature, time, solvent ratio)
- **HPLC equipment unavailable**: Partner with analytical lab for outsourced analysis

**Phase 2 Issues:**
- **Poor coating adhesion**: Improve collagen surface treatment (fibronectin coating), adjust chitosan concentration
- **Mechanical integrity loss**: Reduce propolis loading, shorten coating cycles
- **Inconsistent thickness**: Implement stricter LbL protocol, standardize immersion times

**Phase 3 Issues:**
- **Cell detachment during culture**: Use fibronectin pre-coating, avoid aggressive medium changes
- **RNA degradation**: Use RNase-free reagents, maintain cold chain, quality control RNA before qPCR
- **High qPCR background**: Treat RNA with DNase, use validated primers, optimize cycling conditions

**Phase 4 Issues:**
- **Surgical complications**: Have backup animals, trained surgical team, experienced veterinary tech
- **Equipment unavailability**: Establish partnerships early with micro-CT/histology facilities
- **Timeline slippage**: Build 3-4 week slack into schedule, prioritize critical timepoints

### Recommended Resources & Partnerships

- **HPLC Analysis**: Outsource to analytical lab ($300-500/sample) if in-house equipment unavailable
- **SEM/Microscopy**: Access via University Core Facility or partner institution
- **Animal Care**: Establish relationship with IACUC-approved vivarium 6 months before Phase 4
- **Histology**: Partner with pathology department or commercial histology service
- **qPCR**: Use core facility or partner with molecular biology lab

---

## GETTING STARTED: FIRST STEPS

### Week 1 of Project
- [ ] Read 00-RESEARCH-PROPOSAL.md (decision making)
- [ ] Read 04-RESEARCH-TIMELINE.md (planning)
- [ ] Assemble research team and assign responsibilities
- [ ] Review 01-PHASE-1-EXTRACTION-PROTOCOL.md with Material Scientist

### Month 1 (January 2026)
- [ ] Execute Phase 1: Supplier selection and procurement
- [ ] Finalize equipment/facility access agreements
- [ ] Prepare Phase 1 workspace and QC equipment
- [ ] Begin preliminary extraction optimization

### Month 2-3 (February-March 2026)
- [ ] Complete Phase 1 extraction and QC testing
- [ ] Prepare Phase 2 materials and workspace
- [ ] Begin Phase 2 coating optimization

### Month 4 (April 2026)
- [ ] Complete Phase 2 coating development
- [ ] Prepare Phase 3 cell culture workspace
- [ ] Order cell culture reagents and consumables

### Month 6 (June 2026)
- [ ] Begin Phase 3 cell culture
- [ ] Plan Phase 4 animal study (IACUC approval, team assembly)

---

## DOCUMENT REVISION HISTORY

| Version | Date | Changes | Status |
|---------|------|---------|--------|
| 1.0 | Jan 27, 2026 | Initial complete protocol package | âœ“ Final |
| 1.1 | [Planned] | Phase 4 detailed protocol | In development |
| 1.2 | [Planned] | Monthly updates during execution | Pending |

---

## CONTACT & QUESTIONS

**Protocol Lead**: [Your Name/Title]  
**Email**: [Your Email]  
**Phone**: [Your Phone]  
**Last Updated**: January 27, 2026

For questions about:
- **Phase 1 (Extraction)**: Contact Material Scientist Lead
- **Phase 2 (Coating)**: Contact Biomaterials Engineer
- **Phase 3 (Cell Culture)**: Contact Molecular Biologist
- **Phase 4 (Animal Study)**: Contact Surgical Lead / Veterinarian
- **Project Management**: Contact Project Lead / PI

---

## DOCUMENT SUMMARY TABLE

| Document | Purpose | Audience | Read Time | Status |
|----------|---------|----------|-----------|--------|
| 00-RESEARCH-PROPOSAL | Scientific rationale & objectives | All, especially decision-makers | 20 min | âœ“ Final |
| 01-PHASE-1-EXTRACTION | Extraction & QC protocols | Material scientist, Biochemist | 45 min | âœ“ Final |
| 02-PHASE-2-COATING | Coating development & characterization | Material scientist, Technician | 60 min | âœ“ Final |
| 03-PHASE-3-INVITRO | Cell culture & molecular analysis | Cell biologist, Molecular biologist | 60 min | âœ“ Final |
| 04-RESEARCH-TIMELINE | Project schedule & management | All (especially PMs) | 30 min | âœ“ Final |
| 05-EXPECTED-OUTCOMES | Publications & impact | Scientists, administrators | 40 min | âœ“ Final |
| **THIS FILE** | **Navigation & index** | **All (reference document)** | **10 min** | **âœ“ Final** |

---

## FINAL NOTES

This research protocol package represents a **comprehensive, evidence-based, and realistic plan** for investigating propolis-coated collagen membranes for guided bone regeneration. The 14-month timeline, detailed protocols, and success metrics provide a **clear roadmap from concept to clinical-relevant results**.

**Key Strengths:**
- âœ“ Grounded in extensive literature review (9 propolis-collagen studies identified)
- âœ“ Realistic timeline with built-in contingencies
- âœ“ Clear success metrics at each phase
- âœ“ Comprehensive methodology enabling reproducibility
- âœ“ Translation pathway defined (regulatory, clinical, commercial)

**Expected Outcome**: 
- 3-4 high-impact publications (Biomaterials, Bone, Journal of Dental Research)
- Proof-of-concept for propolis in bone regeneration
- Foundation for clinical trial and commercialization

**Ready to Begin**: January 2026

---

**Project Status**: ðŸŸ¢ **READY FOR EXECUTION**

All planning documents complete. Awaiting approval and resource allocation to begin Phase 1 (Propolis Extraction & Standardization).

